US-based medical device firm Boston Scientific has launched Axios stent and electrocautery enhanced delivery systems to manage two severe complications from pancreatitis via a minimally invasive endoscopic approach.
The Axios system will assist physicians in endoscopic management of pancreatic pseudocysts and several types of walled-off pancreatic necrosis.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The conditions interpret two types of pancreatic fluid collections (PFCs), which take place in 5% to 16% of patients with acute pancreatitis, and 20% to 40% of patients with chronic pancreatitis.
Physicians can use the Axios electrocautery-enhanced catheter to gain access to the PFC, under endoscopic ultrasound (EUS) guidance.
The Axios stent will be deployed to facilitate drainage of the PFC by creating a temporary channel between the PFC and the gastrointestinal tract.
It is reported that the large flanges on each end of the lumen-apposing stent decrease the risk of leakage and migration.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe MRI compatible, fully covered and self-expanding stent is claimed to be the only removable metal stent in the US indicated for PFC drainage.
Axios system inventor Kenneth Binmoeller said: "The Axios stent and electrocautery enhanced delivery system provide a simpler and faster treatment option for patients.
"We can now provide an endoscopic solution that provides immediate relief for these patients using one device in a single setting."
Earlier this month, the company secured FDA approval for its Blazer open-irrigated (OI) radiofrequency ablation catheter to treat Type I atrial flutter, an abnormal rhythm of the upper chambers of the heart.
Image: The Axios system combines a cautery-enabled access catheter with the Axios stent. Photo: courtesy of Boston Scientific Corporation.
